Page last updated: 2024-08-16

resveratrol and Bradycardia

resveratrol has been researched along with Bradycardia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Iliff, BW; Mayers, JR; Swoap, SJ	1
Balulad, SS; Bennett, JA; Keller, RS; Rezk, YA	1

Other Studies

2 other study(ies) available for resveratrol and Bradycardia

Article	Year
Resveratrol treatment in mice does not elicit the bradycardia and hypothermia associated with calorie restriction. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2009, Volume: 23, Issue:4 Topics: Animals; Anti-Obesity Agents; Bradycardia; Caloric Restriction; Exercise Test; Hypothermia; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Physical Endurance; Random Allocation; Resveratrol; Stilbenes; Time Factors	2009
Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart. American journal of obstetrics and gynecology, 2006, Volume: 194, Issue:5 Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bradycardia; Cardiotonic Agents; Cell Division; Cell Survival; Cells, Cultured; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Female; Humans; Long QT Syndrome; Mice; Myocytes, Cardiac; Ovarian Neoplasms; Rats; Resveratrol; Stilbenes; Uterine Neoplasms	2006

Article

Year

Resveratrol treatment in mice does not elicit the bradycardia and hypothermia associated with calorie restriction.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2009, Volume: 23, Issue:4

Topics: Animals; Anti-Obesity Agents; Bradycardia; Caloric Restriction; Exercise Test; Hypothermia; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Physical Endurance; Random Allocation; Resveratrol; Stilbenes; Time Factors

2009

Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart.

American journal of obstetrics and gynecology, 2006, Volume: 194, Issue:5

Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bradycardia; Cardiotonic Agents; Cell Division; Cell Survival; Cells, Cultured; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Female; Humans; Long QT Syndrome; Mice; Myocytes, Cardiac; Ovarian Neoplasms; Rats; Resveratrol; Stilbenes; Uterine Neoplasms

2006